Hila Karah

Hila Karah currently serves as Managing Partner at Pitango Healthtech since September 2022 and holds board positions at multiple companies, including Variantyx, Indaptus Therapeutics, Inc., and OncoHost, all since 2021. Hila has been a Member of the Board of Directors at DarioHealth since November 2014 and previously served on the board of TillaCare Ltd from 2017 until September 2022, as well as Intec Pharma Ltd from 2009 to August 2021. Additional experience includes serving as an Investor and Board Observer at MyHeritage from 2006 to April 2021 and as Executive Chairman at FloraFotonica from 2017 to August 2018. From 2006 to 2013, Hila was the Chief Investment Officer at Eurotrust Ltd. Academic credentials include education from the University of California, Berkeley and UC Berkeley/UCSF.